RPI-78M
Phase 2- Indications
- Multiple Sclerosis, Adrenomyeloneuropathy
Company intelligence / Profile preview
Multiple active companies named "NutraPharm" or similar operate globally, focusing on pharmaceuticals, nutraceuticals, cosmeceuticals, and contract manufacturing. They emphasize high-quality production standards such as cGMP compliance and ISO certification. Their product lines include dietary supplements like spirulina tablets/powder/capsules, natural colorants for food/beverage/animal feed industries, sports proteins, children’s vitamins, skincare creams with novel ingredients/nanotechnology delivery systems. None appear to have a traditional biotech drug pipeline or late-stage clinical programs; their focus remains on commercialized wellness products.[1][2][3][4][5][6]
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NutraPharm.